EDIT: Editas Medicine Inc

2.52 USD 0.12 (4.55%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de EDIT a changé de -4.55% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 2.50 et à un maximum de 2.72.

Suivez la dynamique Editas Medicine Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

EDIT Nouvelles

Zacks 21:40 MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
Seeking Alpha 20:57 Editas Medicine - Primed For An Unlikely Comeback? It's Not Impossible
Zacks 13:44 3 Genomics Stocks Worth Adding to Your Portfolio in 2025
The Motley Fool 09:04 Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?
The Motley Fool 12:15 2 Beaten-Down Stocks to Avoid
Benzinga 17:59 Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst - Eli Lilly (NYSE:LLY), Verve Therapeutics (NASDAQ:VERV)
The Motley Fool 14:07 Editas Medicine Is Great. Here's Why You Shouldn't Buy It.
Investor's Business Daily 13:14 Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
Investing 06:12 Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hema
Investing 20:55 nucana plc announces annual report release and upcoming agm
Investing 21:40 editas medicine amends stock plan and increases authorized shares
The Motley Fool 10:00 1 Stock Down 97% That Could Double, According to Wall Street
Investing 17:59 Chardan cuts Prime Medicine stock target to $12, maintains Buy
Investing 13:50 Cantor maintains Overweight on Astria stock with $47 target
Investing 13:45 Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
Investing 01:03 Editas Medicine at BofA Securities 2025: In Vivo Gene Editing Focus
Seeking Alpha 08:44 CRISPR And Intellia: Balancing Market Uncertainty Against Pipeline Catalysts (NASDAQ:CRSP)
Seeking Alpha 20:07 Editas Medicine, Inc. (EDIT) Barclays 27th Annual Global Healthcare Conference (Transcript)
Seeking Alpha 16:19 Editas Medicine, Inc. (EDIT) Leerink Partners Global Healthcare Conference (Transcript)
Seeking Alpha 22:01 Editas Medicine, Inc. (EDIT) TD Cowen 45th Annual Health Care Conference Transcript

Range quotidien

2.50 2.72

Range Annuel

0.91 5.45

Clôture Précédente: 2.59
Ouverture: 2.64

Bid: 2.52
Ask: 2.82

Plus Bas: 2.50
Plus Haut: 2.72

Volume: 3.720 K

Changement quotidien: -4.55%
Changement Mensuel: 16.67%

Changement à 6 Mois: 100.00%
Changement Annuel: -53.42%

31 juillet, jeudi